Citations 11
The HELIOS Trial Protocol: A Phase III Study of Ibrutinib in Combination with Bendamustine and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia
Hallek, Michael , Österborg, Anders , Chanan‐Khan, Asher , Mahler, Michelle, Salman, Mariya, Wan, Ying , Sun, Steven , Zhuang, Sen Hong, Howes, Angela, Kay, Neil E.
Future Oncology | June 5, 2014 | Volume: 11 | Issue: 1 | Pages: 51-59
